SmithKline Beecham (Cork) Limited
Patent Applications and Registrations
Patent applications and USPTO patent grants for SmithKline Beecham (Cork) Limited.The latest application filed is for "cancer treatment method".
- SmithKline Beecham (Cork) Limited - Carrigaline IE
- SMITHKLINE BEECHAM (CORK) LIMITED -
- SMITHKLINE BEECHAM (CORK) LIMITED - County Cork IE
- SmithKline Beecham (Cork) Limited - Cork
- SMITHKLINE BEECHAM (CORK) LTD. - Curraghbinny, Carrigaline, County Cork IE
- SmithKline Beecham (Cork) Ltd - Cork
- SmithKline Beecham (Cork) Ltd. - Curraghbinny, Carrigaline IE
Trademarks
| Patent | Date |
|---|---|
| Cancer Treatment Method App 20150283139 - Rubin; Stephen | 2015-10-08 |
| Method Of Treating Cancer App 20150231137 - BING; Nan ; et al. | 2015-08-20 |
| Method Of Treating Cancer App 20150023953 - Spraggs; Colin F. | 2015-01-22 |
| Pharmaceutical Composition App 20140335177 - Carter; Barry Howard ; et al. | 2014-11-13 |
| Pharmaceutical composition Grant 8,821,927 - Carter , et al. September 2, 2 | 2014-09-02 |
| Cancer Treatment Method App 20130296261 - Buller; Richard ; et al. | 2013-11-07 |
| Cancer Treatment Method App 20130143834 - Buller; Richard ; et al. | 2013-06-06 |
| Method Of Treating Cancer App 20120156200 - Bing; Nan ; et al. | 2012-06-21 |
| Pyrazolo [1,5-alpha] pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists Grant 8,088,779 - Hossner January 3, 2 | 2012-01-03 |
| Cancer Treatment Method App 20110301185 - Buller; Richard ; et al. | 2011-12-08 |
| Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Grant 7,902,378 - Brook , et al. March 8, 2 | 2011-03-08 |
| Pyrazolo[1,5-alpha]pyrimidinyl derivatives useful as corticotropin-releasing factor (CRF) receptor antagonists Grant 7,879,862 - Lanier , et al. February 1, 2 | 2011-02-01 |
| Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Grant 7,759,384 - Brook , et al. July 20, 2 | 2010-07-20 |
| CRF receptor antagonists and methods relating thereto Grant 7,737,154 - Luo , et al. June 15, 2 | 2010-06-15 |
| Cancer Treatment Method App 20100069411 - Buller; Richard ; et al. | 2010-03-18 |
| Carvedilol phosphate salts and/or solvates thereof, corresponding compositions, and/or methods of treatment Grant 7,626,041 - Brook , et al. December 1, 2 | 2009-12-01 |
| Cancer Treatment Method App 20090203718 - Rusnak; David ; et al. | 2009-08-13 |
| Cancer Treatment Method App 20080306097 - Rubin; Stephen | 2008-12-11 |
| Tri-and tetraaza-acenaphthylen derivatives as CRF receptor antagonists Grant 7,446,108 - Di Fabio , et al. November 4, 2 | 2008-11-04 |
| Quinazoline ditosylate salt compounds Grant 7,157,466 - McClure , et al. January 2, 2 | 2007-01-02 |
| Cancer treatment method Grant 7,141,576 - Lackey , et al. November 28, 2 | 2006-11-28 |
| Polymorph of 5-[4-[2-(n-methyl-n(2-pyridyl)amino)ethoxy]benzyl]-thiazolidine-2,4-dione, maleic acid salt Grant 6,806,280 - Blackler , et al. October 19, 2 | 2004-10-19 |
uspto.report is an independent third-party trademark research tool that is not affiliated, endorsed, or sponsored by the United States Patent and Trademark Office (USPTO) or any other governmental organization. The information provided by uspto.report is based on publicly available data at the time of writing and is intended for informational purposes only.
While we strive to provide accurate and up-to-date information, we do not guarantee the accuracy, completeness, reliability, or suitability of the information displayed on this site. The use of this site is at your own risk. Any reliance you place on such information is therefore strictly at your own risk.
All official trademark data, including owner information, should be verified by visiting the official USPTO website at www.uspto.gov. This site is not intended to replace professional legal advice and should not be used as a substitute for consulting with a legal professional who is knowledgeable about trademark law.
| 